Ovine Forestomach Matrix in the Surgical Management of Complex Lower-Extremity Soft-Tissue Defects
Journal of the American Podiatric Medical Association · 2023
DOI: 10.7547/22-081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Podiatric Medical Association, 2023. Verfasst von Brandon A Bosque und 10 weiteren Autor:innen. Beteiligte Einrichtung: *Aroa Biosurgery, Research and Clinical Development, San Diego, CA. Hauptthemen laut MEDLINE: Quality of Life, Plastic Surgery Procedures. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Background
Chronic lower-extremity defects may lead to major amputations and have severe consequences on patient quality of life and mortality. Dermal matrices have become part of the reconstructive ladder and are often deployed in these scenarios to quickly build neodermis, especially in volumetric defects over exposed bone and tendon initially, to allow for subsequent closure by means of split-thickness skin grafting (STSG) or secondary intention. Ovine forestomach matrix (OFM) is a decellularized extracellular matrix (ECM) bioscaffold available in both sheet and particulate forms that can be used as a dermal matrix in various soft-tissue reconstruction procedures.
Methods
This retrospective case series evaluated the use of OFM products in the surgical reconstruction of 50 cases (n = 50) comprised of challenging lower-extremity defects from seven healthcare centers. Patient records were reviewed to identify comorbidities, defect cause, defect size, presence of exposed structures, Centers for Disease Control and Prevention contamination score, Wagner grade, OFM graft use, time to 100% granulation tissue, STSG use, overall time to heal, and postoperative complications. The primary study outcomes were time (days) to 100% granulation tissue formation, with secondary outcomes including overall time to wound closure (weeks), STSG take at 1 week, and complications.
Results
The results of this case series demonstrate OFM as a clinically effective treatment in the surgical management of complex lower-extremity soft-tissue defects with exposed structures in patients with multiple comorbidities. One application of OFM products was effective in regenerating well-vascularized neodermis, often in the presence of exposed structures, with a mean time to 100% granulation of 26.0 ± 22.2 days.
Conclusions
These data support the use of OFM as a safe, cost-effective, and clinically effective treatment option for coverage in complex soft-tissue wounds, including exposed vital structures, and to shorten the time to definitive wound closure in complicated patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- *Aroa Biosurgery, Research and Clinical Development, San Diego, CA.
- †Ankle and Foot Centers of America, Roswell, GA.
- ‡Memorial Hospital Pembroke, Davie, FL.
- §Scripps Mercy Hospital, Chula Vista, CA.
- ‖Ephraim McDowell Regional Medical Center, Danville, KY.
- ¶Northwestern Medicine-Palos Hospital, Palos Heights, IL.
Zitieren
APA
Bosque, B. A., Dowling, S. G., May, B. C. H., Kaufman, R., Zilberman, I., Zolfaghari, N., Que, H., Longobardi, J., Skurka, J., Geiger, J. E., & Melin, M. M. (2023). Ovine Forestomach Matrix in the Surgical Management of Complex Lower-Extremity Soft-Tissue Defects. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/22-081
Vancouver
Bosque BA, Dowling SG, May BCH, Kaufman R, Zilberman I, Zolfaghari N, et al. Ovine Forestomach Matrix in the Surgical Management of Complex Lower-Extremity Soft-Tissue Defects. Journal of the American Podiatric Medical Association. 2023. doi:10.7547/22-081
BibTeX
@article{Bosque2023,
author = {Bosque, Brandon A and Dowling, Shane G and May, Barnaby C H and Kaufman, Richard and Zilberman, Igor and Zolfaghari, Nooshin and Que, Howie and Longobardi, James and Skurka, Joseph and Geiger, James E and Melin, M Mark},
title = {Ovine Forestomach Matrix in the Surgical Management of Complex Lower-Extremity Soft-Tissue Defects},
journal = {Journal of the American Podiatric Medical Association},
year = {2023},
doi = {10.7547/22-081}
}
EUVIMED